The deficiency of immunoregulatory receptor PD-1 causes mild osteopetrosis

Bone

Volumn 35, Issue 5, 2004, Pages 1059-1068

  Nagahama, K ^a   Aoki, K ^a   Nonaka, K ^a   Saito, H ^a   Takahashi, M ^a   Varghese, B J ^a   Shimokawa, H ^a   Azuma, M ^a   Ohya, K ^a   Ohyama, K ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Immunoregulatory receptor; Osteoclastogenesis; Osteopetrosis; Programmed death 1 (PD 1)

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; IMMUNOGLOBULIN; OSTEOCLAST DIFFERENTIATION FACTOR; PROGRAMMED CELL DEATH 1; PROTEIN; UNCLASSIFIED DRUG;

ALBERS SCHOENBERG DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE MINERAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORTICAL BONE; IMMUNOREGULATION; MORPHOMETRICS; MOUSE; NONHUMAN; OSSIFICATION; OSTEOCLAST; PHENOTYPE; SPLEEN CELL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRABECULAR BONE;

ANIMALS; ANTIGENS, SURFACE; APOPTOSIS REGULATORY PROTEINS; BONE DENSITY; BONE MARROW CELLS; CELL DIFFERENTIATION; GENE EXPRESSION; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OSTEOBLASTS; OSTEOCLASTS; OSTEOPETROSIS; PHENOTYPE; TIBIA;

EID: 8444225359     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2004.06.018     Document Type: Article

References (42)

1. J. Li, I. Sarosi, X.Q. Yan, S. Morony, C. Capparelli, and H.L. Tan RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism Proc. Natl. Acad. Sci. U. S. A. 97 2000 1566 1571
2. Y.Y. Kong, H. Yoshida, I. Sarosi, H.L. Tan, E. Timms, and C. Capparelli OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis Nature 397 1999 315 323
3. L.E. Theill, W.J. Boyle, and J.M. Penninger RANK-L and RANK: T cells, bone loss, and mammalian evolution Annu. Rev. Immunol. 20 2002 795 823
4. D.M. Anderson, E. Maraskovsky, W.L. Billingsley, W.C. Dougall, M.E. Tometsko, and E.R. Roux A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function Nature 390 1997 175 179
5. B.R. Wong, R. Josien, S.Y. Lee, B. Sauter, H.L. Li, and R.M. Steinman TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor J. Exp. Med. 186 1997 2075 2080
6. Y.Y. Kong, U. Feige, I. Sarosi, B. Bolon, A. Tafuri, and S. Morony Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand Nature 402 1999 304 309
7. Y.T. Teng, H. Nguyen, X. Gao, Y.Y. Kong, R.M. Gorczynski, and B. Singh Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection J. Clin. Invest. 106 2000 59 67
8. H. Takayanagi, K. Ogasawara, S. Hida, T. Chiba, S. Murata, and K. Sato T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ Nature 408 2000 600 605
9. J.R. Arron, and Y. Choi Bone versus immune system Nature 408 2000 535 536
10. R. Baron Arming the osteoclast Nat. Med. 10 2004 458 460
11. T. Koga, M. Inui, K. Inoue, S. Kim, A. Suematsu, and E. Kobayashi Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis Nature 428 2004 758 763
12. A. Mocsai, M.B. Humphrey, J.A. Van Ziffle, Y. Hu, A. Burghardt, and S.C. Spusta The immunomodulatory adapter proteins DAP12 and Fc receptor gamma-chain (FcRgamma) regulate development of functional osteoclasts through the Syk tyrosine kinase Proc. Natl. Acad. Sci. U. S. A. 101 2004 6158 6163
13. P. Waterhouse, J.M. Penninger, E. Timms, A. Wakeham, A. Shahinian, and K.P. Lee Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4 Science 270 1995 985 988
14. E.A. Tivol, F. Borriello, A.N. Schweitzer, W.P. Lynch, J.A. Bluestone, and A.H. Sharpe Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4 Immunity 3 1995 541 547
15. H. Nishimura, and T. Honjo PD-1: an inhibitory immunoreceptor involved in peripheral tolerance Trends Immunol. 22 2001 265 268
16. Y. Ishida, Y. Agata, K. Shibahara, and T. Honjo Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death EMBO J. 11 1992 3887 3895
17. Y. Agata, A. Kawasaki, H. Nishimura, Y. Ishida, T. Tsubata, and H. Yagita Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes Int. Immunol. 8 1996 765 772
18. A.H. Sharpe, and G.J. Freeman The B7-CD28 superfamily Nat. Rev., Immunol. 2 2002 116 126
19. G.J. Freeman, A.J. Long, Y. Iwai, K. Bourque, T. Chernova, and H. Nishimura Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation J. Exp. Med. 92 2000 1027 1034
20. H. Dong, G. Zhu, K. Tamada, and L. Chen B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion Nat. Med. 5 1999 1365 1369
21. S.Y. Tseng, M. Otsuji, K. Gorski, X. Huang, J.E. Slansky, and S.I. Pai B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells J. Exp. Med. 93 2001 839 846
22. Y. Latchman, C.R. Wood, T. Chernova, D. Chaudhary, M. Borde, and I. Chernova PD-L2 is a second ligand for PD-1 and inhibits T cell activation Nat. Immunol. 2 2001 261 268
23. T. Yamazaki, H. Akiba, H. Iwai, H. Matsuda, M. Aoki, and Y. Tanno Expression of programmed death 1 ligands by murine T cells and APC J. Immunol. 169 2002 5538 5545
24. T. Okazaki, A. Maeda, H. Nishimura, T. Kurosaki, and T. Honjo PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine Proc. Natl. Acad. Sci. U. S. A. 98 2001 13866 13871
25. L.M. Shlapatska, S.V. Mikhalap, A.G. Berdova, O.M. Zelensky, T.J. Yun, and K.E. Nichols CD150 association with either the SH2-containing inositol phosphatase or the SH2-containing protein tyrosine phosphatase is regulated by the adaptor protein SH2D1A J. Immunol. 166 2001 5480 5487
26. H. Nishimura, M. Nose, H. Hiai, N. Minato, and T. Honjo Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor Immunity 11 1999 141 151
27. H. Nishimura, T. Okazaki, Y. Tanaka, K. Nakatani, M. Hara, and A. Matsumori Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice Science 291 2001 319 322
28. H. Nishimura, N. Minato, T. Nakano, and T. Honjo Immunological studies on PD-1 deficient mice: implication of PD-1 as a negative regulator for B cell responses Int. Immunol. 10 1998 1563 1572
29. v mutant mice Bone 25 1999 261 267
30. A.M. Parfitt, M.K. Drezner, F.H. Glorieux, J.A. Kanis, H. Malluche, and P.J. Meunier Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee J. Bone Miner. Res. 2 1987 595 610
31. H. Seto, K. Aoki, S. Kasugai, and K. Ohya Trabecular bone turnover, bone marrow cell development, and gene expression of bone matrix proteins after low calcium feeding in rats Bone 25 1999 687 695
32. E. Jimi, I. Nakamura, H. Amano, Y. Taguchi, T. Tsurukai, and M. Tamura Osteoclast function is activated by osteoblastic cells through a mechanism involving cell-to-cell contact Endocrinology 137 1996 2187 2190
33. F. Tsushima, H. Iwai, N. Otsuki, M. Abe, S. Hirose, and T. Yamazaki Preferential contribution of B7-H1 to programmed death-1-mediated regulation of hapten-specific allergic inflammatory responses Eur. J. Immunol. 33 2003 2773 2782
34. S.L. Teitelbaum, and F.P. Ross Genetic regulation of osteoclast development and function Nat. Rev., Genet. 4 2003 638 649
35. A.E. Grigoriadis, Z.Q. Wang, M.G. Cecchini, W. Hofstetter, R. Felix, and H.A. Fleisch c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling Science 266 1994 443 448
36. P. Soriano, C. Montgomery, R. Geske, and A. Bradley Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice Cell 64 1991 693 702
37. K.P. McHugh, K. Hodivala-Dilke, M.H. Zheng, N. Namba, J. Lam, and D. Novack Mice lacking β3 integrins are osteosclerotic because of dysfunctional osteoclasts J. Clin. Invest. 105 2000 433 440
38. Y. Choi, K.M. Woo, S.H. Ko, Y.J. Lee, S.J. Park, and H.M. Kim Osteoclastogenesis is enhanced by activated B cells but suppressed by activated CD8(+) T cells Eur. J. Immunol. 31 2001 2179 2188
39. L. Carter, L.A. Fouser, J. Jussif, L. Fitz, B. Deng, and C.R. Wood PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2 Eur. J. Immunol. 32 2002 634 643
40. C.A. Chambers, M.F. Krummel, B. Boitel, A. Hurwitz, T.J. Sullivan, and S. Fournier The role of CTLA-4 in the regulation and initiation of T-cell responses Immunol. Rev. 153 1996 27 46
41. P.S. Linsley, J.L. Greene, W. Brady, J. Bajorath, J.A. Ledbetter, and R. Peach Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors Immunity 1 1994 793 801
42. S. Wang, J. Bajorath, D.B. Flies, H. Dong, T. Honjo, and L. Chen Molecular modeling and functional mapping of B7-H1 and B7-DC uncouple costimulatory function from PD-1 interaction J. Exp. Med. 97 2003 1083 1091